Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027
- 1 June 2008
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 57 (6) , 709-716
- https://doi.org/10.1099/jmm.0.47711-0
Abstract
The first Dutch outbreak due to Clostridium difficile ribotype 027 was observed in mid-2005; by the end of that year, eight hospitals were affected. To study the relationship between hospital-wide antibiotic use and the incidence of 027-linked C. difficile-associated disease (CDAD) three study groups were made: group A, all eight hospitals with an 027-associated epidemic; group B, five of a total of six hospitals with occasional 027 cases, without an increase in CDAD; and group C, ten randomly selected hospitals with no reported 027 epidemics or isolated 027 cases. Quarterly data on CDAD incidences, hygiene measures and the use of fluoroquinolones, second- and third-generation cephalosporins, extended-spectrum penicillins, penicillins with beta-lactamase inhibitors, carbapenems, lincomycins and macrolides were collected for 2004 and 2005, and divided into pre-epidemic and epidemic periods. Using a multilevel Poisson regression analysis, CDAD incidence was linked to antibiotic use in the previous quarter and to certain hygiene measures. In the pre-epidemic period, the total use of the studied antibiotics was comparable between affected and unaffected hospitals. Higher use of second-generation cephalosporins, macrolides and all of the studied antibiotics were independently associated with a small increase in CDAD incidence [relative risk (95 % confidence interval): 1.14 per increase of 100 defined daily doses per 10 000 bed days (1.06–1.23), 1.10 (1.01–1.19) and 1.02 (1.01–1.03), respectively]. However the effect was too small to predict which hospitals might be more prone to 027-associated outbreaks.Keywords
This publication has 27 references indexed in Scilit:
- Spread and Epidemiology of Clostridium difficile Polymerase Chain Reaction Ribotype 027/Toxinotype III in The NetherlandsClinical Infectious Diseases, 2007
- Efficacy of Hospital Cleaning Agents and Germicides Against EpidemicClostridium difficileStrainsInfection Control & Hospital Epidemiology, 2007
- Clinical Features ofClostridium difficile–Associated Infections and Molecular Characterization of Strains: Results of a Retrospective Study, 2000-2004Infection Control & Hospital Epidemiology, 2007
- Clostridium difficile-Associated Disease in Oregon: Increasing Incidence and Hospital-Level Risk FactorsInfection Control & Hospital Epidemiology, 2007
- Moxifloxacin Therapy as a Risk Factor forClostridium difficile–Associated Disease During an Outbreak: Attempts to Control a New Epidemic StrainInfection Control & Hospital Epidemiology, 2007
- A Portrait of the Geographic Dissemination of the Clostridium difficile North American Pulsed-Field Type 1 Strain and the Epidemiology of C. difficile-Associated Disease in QuebecClinical Infectious Diseases, 2007
- Management of an Outbreak ofClostridium difficile–Associated Disease Among Geriatric PatientsInfection Control & Hospital Epidemiology, 2006
- A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and MortalityNew England Journal of Medicine, 2005
- Outbreak ofClostridium difficileInfection in a Long‐Term Care Facility: Association with Gatifloxacin UseClinical Infectious Diseases, 2004
- Management and control of a large outbreak of diarrhoea due to Clostridium difficileJournal of Hospital Infection, 1994